K
Kristien Keymeulen
Researcher at Maastricht University
Publications - 53
Citations - 1166
Kristien Keymeulen is an academic researcher from Maastricht University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 17, co-authored 44 publications receiving 890 citations. Previous affiliations of Kristien Keymeulen include Maastricht University Medical Centre.
Papers
More filters
Journal ArticleDOI
Improved overall survival after contralateral risk-reducing mastectomy in brca1/2 mutation carriers with a history of unilateral breast cancer : A prospective analysis
Bernadette A M Heemskerk-Gerritsen,Matti A. Rookus,Cora M. Aalfs,Margreet G. E. M. Ausems,J. M. Collee,Liesbeth Jansen,C. Marleen Kets,Kristien Keymeulen,Linetta B. Koppert,Hanne Meijers-Heijboer,T.M. Mooij,Rob A. E. M. Tollenaar,Hans F. A. Vasen,Maartje J. Hooning,Caroline Seynaeve +14 more
TL;DR: It is concluded that CRRM is associated with improved overall survival in BRCA1/2 mutation carriers with a history of PBC, and survival benefit was especially seen in young PBC patients (<40 years, in patients having a PBC with differentiation grade 1/2 and/or no triple‐negative phenotype, and in patients not treated with adjuvant chemotherapy.
Journal ArticleDOI
'Reconstruction: before or after postmastectomy radiotherapy?' A systematic review of the literature.
Judith Berbers,Angela van Baardwijk,Ruud Houben,Esther M. Heuts,Marjolein L. Smidt,Kristien Keymeulen,Maud Bessems,Stefania Tuinder,Liesbeth J. Boersma +8 more
TL;DR: A definite implant reconstruction placed before radiotherapy limits the rate of complications and for autologous reconstruction, less fibrosis is seen if reconstruction is performed after radiotherapy, but timing had no significant impact on total complication rate.
Journal ArticleDOI
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
S. Saadatmand,H Amarens Geuzinge,Emiel J. Th. Rutgers,Ritse M. Mann,Diderick B W de Roy van Zuidewijn,H. M. Zonderland,Rob A. E. M. Tollenaar,Marc B. I. Lobbes,Margreet G. E. M. Ausems,Martijne van 't Riet,Maartje J. Hooning,Ingeborg Mares-Engelberts,Ernest J. T. Luiten,Eveline A.M. Heijnsdijk,Cees Verhoef,Nico Karssemeijer,Jan C. Oosterwijk,Inge-Marie Obdeijn,Harry J. de Koning,Madeleine M. A. Tilanus-Linthorst,Carolien H.M. van Deurzen,Claudette E. Loo,Jelle Wesseling,Margrethe Schlooz-Vries,Suzan van der Meij,Wilma E. Mesker,Kristien Keymeulen,Carolien Contant,Eva V. E. Madsen,Linetta B. Koppert,Joost Rothbarth,Wouter B. Veldhuis,Arjen J Witkamp,Eric Tetteroo,Cécile de Monyé,Mandy M van Rosmalen,Jolanda Remmelzwaal,Huub B W Gort,Roelie Roi-Antonides,Martin N. J. M. Wasser,Edith van Druten +40 more
TL;DR: MRI screening detected cancers at an earlier stage than mammography in women with familial risk of breast cancer, and the lower number of late-stage cancers identified in incident rounds might reduce the use of adjuvant chemotherapy and decrease breast cancer-related mortality.
Journal ArticleDOI
The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review.
V. J. L. Kuijs,M. Moossdorff,M. Moossdorff,Robert-Jan Schipper,Robert-Jan Schipper,Regina G. H. Beets-Tan,Regina G. H. Beets-Tan,Esther M. Heuts,Kristien Keymeulen,Marjolein L. Smidt,Marjolein L. Smidt,Marc B. I. Lobbes +11 more
TL;DR: The diagnostic performance of some MRI protocols for excluding axillary lymph node metastases approaches the NPV needed to replace SLNB, however, current observations are based on studies with heterogeneous study designs and limited populations.
Journal ArticleDOI
Acquired resistance to the Hedgehog pathway inhibitor vismodegib due to smoothened mutations in treatment of locally advanced basal cell carcinoma
Tjinta Brinkhuizen,M.G.H.C. Reinders,Michel van Geel,Annelot J L Hendriksen,Aimee D C Paulussen,Véronique Winnepenninckx,Kristien Keymeulen,Patricia M. M. B. Soetekouw,Maurice A.M. van Steensel,Klara Mosterd +9 more